KNOWLEDGE INFLUENCE IN THE COMPLIANCE RATE OF TAKING DRUGS TUBERCULOSIS
DOI:
https://doi.org/10.36423/pharmacoscript.v6i2.1285Keywords:
Education, Adherence, Knowledge, Tuberculosis, Family EnvironmentAbstract
Compliance with medication for tuberculosis patients is one of the determinants of the success of therapy in addition to the effectiveness of antibiotics. The aim of this study is to identify the factors that influence the success of a therapy, in the long-term use of antibiotics for tuberculosis. We use questionnaires that we have created and validated in interviews and can be used to directly measure the level of compliance with the therapy experienced by the patient. This research method is an observational study with cross-sectional design and retrospective data collection. Respondents were patients with tuberculosis, both new and recurrent. The study sample consisted of 30 respondents with sequential sampling selection and the basis for patient interviews. The analysis used is a Chi-square binary between a variable in the history of tuberculosis with a long diagnosis during therapy that shows a relationship between education and family involvement in helping treatment especially in male patients with a P value <0,05. Multivariate analysis showed that men who never completed education even though they were still in a productive age had a low level of compliance. The results of the interviews showed that patients who obeyed the drug only reached 30% with scores reaching a score of 8. This is due to the large amount of medication taken, so the risk of success of therapy is very large. This research shows that the level of education, information, and family environment can support patient medication compliance. In addition, the more the amount of medication taken, the lower the patient's compliance.References
Benzekri, N. A., Sambou, J. F., Tamba, I. T., Diatta, J. P., Sall, I., Cisse, O., Thiam, M., Bassene, G., Badji, N. M., Faye, K., Sall, F., Malomar, J. J., Seydi, M., & Gottlieb, G. S. (2019). Nutrition support for HIV-TB co-infected adults in Senegal, West Africa: A randomized pilot implementation study. PloS One, 14(7), e0219118. https://doi.org/10.1371/journal.pone.0219118
Dayer LE, Shilling R, Van Valkenburg M, et al. 2017. Assessing the medication adherence app market place from the health professional and consumer vantage points. JMIR M health U health. 5(4):e45.
Frijters, E. M., Hermans, L. E., Wensing, A. M. J., Devillé, W. L. J. M., Tempelman, H. A., & De Wit, J. B. F. (2020). Risk factors for loss to follow-up from antiretroviral therapy programmes in low-income and middle-income countries. AIDS (London, England), 34(9), 1261–1288. https://doi.org/10.1097/QAD.0000000000002523
Gube AD, et al. 2017. Assesment of Anti-TB Drug Nonadherenceand associated Factor among TB Patient Attending TB Clinicsin Arba Minch Governmental Health Institutions, Southern Ethopia. Tuberculosis Research and Treatment. ID 3705812, 7;doi.org/10.1155/2018/3705812
Hanlon, P., Yeoman, L., Gibson, L., Esiovwa, R., Williamson, A. E., Mair, F. S., & Lowrie, R. (2018). A systematic review of interventions by healthcare professionals to improve management of non-communicable diseases and communicable diseases requiring long-term care in adults who are homeless. BMJ Open, 8(4), e020161. https://doi.org/10.1136/bmjopen-2017-020161
Haramiova, Z., Stasko, M., Hulin, M., Tesar, T., Kuzelova, M., & Morisky, D. M. (2017). The effectiveness of daily SMS reminders in pharmaceutical care of older adults on improving patients’ adherence to antihypertensive medication (SPPA): study protocol for a randomized controlled trial. Trials, 18(1), 334. https://doi.org/10.1186/s13063-017-2063-8
Htun, Y. M., Khaing, T. M. M., Aung, N. M., Yin, Y., Myint, Z., Aung, S. T., Soonthornworasiri, N., Silachamroon, U., Kasetjaroen, Y., & Kaewkungwal, J. (2018). Delay in treatment initiation and treatment outcomes among adult patients with multidrug-resistant tuberculosis at Yangon Regional Tuberculosis Centre, Myanmar: A retrospective study. PloS One, 13(12), e0209932. https://doi.org/10.1371/journal.pone.0209932
Karuniawati, H., Putra, O. N., & Wikantyasning, E. R. (2019). Impact of pharmacist counseling and leaflet on the adherence of pulmonary tuberculosis patients in lungs hospital in Indonesia. The Indian Journal of Tuberculosis, 66(3), 364–369. https://doi.org/10.1016/j.ijtb.2019.02.015
Khachadourian, V., Truzyan, N., Harutyunyan, A., Petrosyan, V., Davtyan, H., Davtyan, K., van den Boom, M., & Thompson, M. E. (2020). People-centred care versus clinic-based DOT for continuation phase TB treatment in Armenia: a cluster randomized trial. BMC Pulmonary Medicine, 20(1), 105. https://doi.org/10.1186/s12890-020-1141-y
Morawsky K., et al. 2018. Association of a smartphone Application With Medication Adherence and Blood Pressure Control. JAMA interm Med. .doi:10.1001/jamainternmed.2018.0447.
Nunn, A. J., Phillips, P. P. J., Meredith, S. K., Chiang, C.-Y., Conradie, F., Dalai, D., van Deun, A., Dat, P.-T., Lan, N., Master, I., Mebrahtu, T., Meressa, D., Moodliar, R., Ngubane, N., Sanders, K., Squire, S. B., Torrea, G., Tsogt, B., & Rusen, I. D. (2019). A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis. The New England Journal of Medicine, 380(13), 1201–1213. https://doi.org/10.1056/NEJMoa1811867
Puchalski Ritchie, L. M., van Lettow, M., Makwakwa, A., Kip, E. C., Straus, S. E., Kawonga, H., Hamid, J. S., Lebovic, G., Thorpe, K. E., Zwarenstein, M., Schull, M. J., Chan, A. K., Martiniuk, A., & van Schoor, V. (2020). Impact of a tuberculosis treatment adherence intervention versus usual care on treatment completion rates: results of a pragmatic cluster randomized controlled trial. Implementation Science : IS, 15(1), 107. https://doi.org/10.1186/s13012-020-01067-y
Ruan, Q.-L., Huang, X.-T., Yang, Q.-L., Liu, X.-F., Wu, J., Pan, K.-C., Shen, Y.-J., Cai, L.-M., Ling, Q., Jiang, T., Hong, J.-J., Wang, X.-D., Ma, C.-L., Peng, G.-Q., Wang, X.-Z., Mao, J.-C., Wu, T.-Z., Lin, M.-Y., Shao, L.-Y., & Zhang, W.-H. (2021). Efficacy and safety of weekly rifapentine and isoniazid for tuberculosis prevention in Chinese silicosis patients: a randomized controlled trial. Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 27(4), 576–582. https://doi.org/10.1016/j.cmi.2020.06.008
Tola, H. H., Holakouie-Naieni, K., Tesfaye, E., Mansournia, M. A., & Yaseri, M. (2019). Prevalence of tuberculosis treatment non-adherence in Ethiopia: a systematic review and meta-analysis. The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union against Tuberculosis and Lung Disease, 23(6), 741–749. https://doi.org/10.5588/ijtld.18.0672
Tweed, C. D., Dawson, R., Burger, D. A., Conradie, A., Crook, A. M., Mendel, C. M., Conradie, F., Diacon, A. H., Ntinginya, N. E., Everitt, D. E., Haraka, F., Li, M., van Niekerk, C. H., Okwera, A., Rassool, M. S., Reither, K., Sebe, M. A., Staples, S., Variava, E., & Spigelman, M. (2019). Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial. The Lancet. Respiratory Medicine, 7(12), 1048–1058. https://doi.org/10.1016/S2213-2600(19)30366-2
Zegeye, A., Dessie, G., Wagnew, F., Gebrie, A., Islam, S. M. S., Tesfaye, B., & Kiross, D. (2019). Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: A systematic review and meta-analysis. PloS One, 14(1), e0210422. https://doi.org/10.1371/journal.pone.0210422
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Kamri Andi Maulana, Asmaliani Ira
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication, with the work [SPECIFY PERIOD OF TIME] after publication simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This Journal is licensed under a 